These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 16040385)

  • 21. Enhancement of T cell activation by immobilized hu5C8 (anti-CD40L) monoclonal antibody.
    Arpinati M; Chirumbolo G; Rondelli D
    Eur J Haematol; 2008 Apr; 80(4):322-30. PubMed ID: 18081708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human antibody response in human peripheral blood leukocyte/severe combined immunodeficient chimeric model is dependent on B and T cell costimulation via CD40/CD40 ligand.
    Chen FA; Williams SS; Fanslow WC; Bankert RB
    J Immunol; 1995 Sep; 155(6):2833-40. PubMed ID: 7673699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel immunotherapy to hepatocellular carcinoma: CD40-activated B lymphocytes transfected with AFPmRNA.
    Wan Y; Ma X; Li X; Yi J
    Med Hypotheses; 2009 Nov; 73(5):835-7. PubMed ID: 19632790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD40.FasL inhibits human T cells: evidence for an auto-inhibitory loop-back mechanism.
    Dranitzki-Elhalel M; Huang JH; Sasson M; Rachmilewitz J; Parnas M; Tykocinski ML
    Int Immunol; 2007 Apr; 19(4):355-63. PubMed ID: 17314083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through the release of soluble CD40.
    van Kooten C; Gaillard C; Galizzi JP; Hermann P; Fossiez F; Banchereau J; Blanchard D
    Eur J Immunol; 1994 Apr; 24(4):787-92. PubMed ID: 7512028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ex vivo induction of viral antigen-specific CD8 T cell responses using mRNA-electroporated CD40-activated B cells.
    Van den Bosch GA; Ponsaerts P; Nijs G; Lenjou M; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
    Clin Exp Immunol; 2005 Mar; 139(3):458-67. PubMed ID: 15730391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antigen specificity of dual reactive T hybridomas determines the requirement for CD40 ligand-CD40 interactions.
    Ozaki ME; Karlsson L; Peterson PA; Webb SR
    J Immunol; 1997 Jul; 159(1):214-21. PubMed ID: 9200457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of B-cell chronic lymphocytic leukemia (B-CLL)-reactive T-cell lines and clones from HLA class I-matched donors using modified B-CLL cells as stimulators: implications for adoptive immunotherapy.
    Hoogendoorn M; Wolbers JO; Smit WM; Schaafsma MR; Barge RM; Willemze R; Falkenburg JH
    Leukemia; 2004 Jul; 18(7):1278-87. PubMed ID: 15116118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of myelin-specific antigen presenting B cells on T cell activation in multiple sclerosis.
    Harp CT; Lovett-Racke AE; Racke MK; Frohman EM; Monson NL
    Clin Immunol; 2008 Sep; 128(3):382-91. PubMed ID: 18599355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential immaturity of the T-cell and antigen-presenting cell interaction in cord blood with particular emphasis on the CD40-CD40 ligand costimulatory pathway.
    Han P; McDonald T; Hodge G
    Immunology; 2004 Sep; 113(1):26-34. PubMed ID: 15312133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cleavage of membrane-bound CD40 ligand is not required for inducing B cell proliferation and differentiation.
    Pietravalle F; Lecoanet-Henchoz S; Aubry JP; Elson G; Bonnefoy JY; Gauchat JF
    Eur J Immunol; 1996 Mar; 26(3):725-8. PubMed ID: 8605945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rebuilding human leukocyte antigen class II-restricted minor histocompatibility antigen specificity in recall antigen-specific T cells by adoptive T cell receptor transfer: implications for adoptive immunotherapy.
    Spaapen R; van den Oudenalder K; Ivanov R; Bloem A; Lokhorst H; Mutis T
    Clin Cancer Res; 2007 Jul; 13(13):4009-15. PubMed ID: 17606735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD40L, CD28, and CTLA-4 expression on CD4+ T cells in kidney graft recipients: a relationship with post-transplantation clinical course.
    Kosmaczewska A; Magott-Procelewska M; Frydecka I; Ciszak L; Bocko D; Szteblich A; Kusnierczyk P; Patrzalek D; Szyber P; Klinger M
    Transpl Immunol; 2006 Jun; 16(1):32-40. PubMed ID: 16701174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
    Xia G; Truitt RL; Johnson BD
    Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B cells play a cooperative role via CD40L-CD40 interaction in T cell-mediated experimental autoimmune neuritis in Lewis rats.
    Zhu W; Mix E; Jin T; Adem A; Zhu J
    Neurobiol Dis; 2007 Mar; 25(3):642-8. PubMed ID: 17188497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation and characterization of a novel anti-rat CD40L antibody with inhibitory activities in vitro and in vivo.
    Stax AM; Gelderman KA; Kamerling SW; van der Geest R; Schlagwein N; van Kooten C
    J Immunol Methods; 2008 Jun; 335(1-2):46-52. PubMed ID: 18384807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A class II-restricted cytotoxic T-cell clone recognizes a human minor histocompatibility antigen with a restricted tissue distribution.
    Holloway PA; Kaldenhoven N; Kok-Schoemaker HM; Dijk Mv; Otten HG; Tilanus M; Postma S; Mutis T; Lokhorst HM; Bloem AC
    Br J Haematol; 2005 Jan; 128(1):73-81. PubMed ID: 15606552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TLR9 stimulation drives naïve B cells to proliferate and to attain enhanced antigen presenting function.
    Jiang W; Lederman MM; Harding CV; Rodriguez B; Mohner RJ; Sieg SF
    Eur J Immunol; 2007 Aug; 37(8):2205-13. PubMed ID: 17621369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional and in situ evidence for nitric oxide production driven by CD40-CD40L interactions in graft-versus-leukemia reactivity.
    Müerköster S; Laman JD; Rocha M; Umansky V; Schirrmacher V
    Clin Cancer Res; 2000 May; 6(5):1988-96. PubMed ID: 10815924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization and application of two novel monoclonal antibodies against CD40L: epitope and functional studies on cell membrane CD40L and studies on the origin of soluble serum CD40L.
    Fan Y; Ge Y; Zhu H; Wang Y; Yang B; Zhuang Y; Ma H; Zhang X
    Tissue Antigens; 2004 Sep; 64(3):257-63. PubMed ID: 15304006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.